Zoi Kanaki

708 total citations
19 papers, 510 citations indexed

About

Zoi Kanaki is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Zoi Kanaki has authored 19 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Oncology. Recurrent topics in Zoi Kanaki's work include Epigenetics and DNA Methylation (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and DNA Repair Mechanisms (2 papers). Zoi Kanaki is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and DNA Repair Mechanisms (2 papers). Zoi Kanaki collaborates with scholars based in Greece, United States and Germany. Zoi Kanaki's co-authors include Apostolos Klinakis, Eleni Vasilaki, Nikolaos Paschalidis, George Papafotiou, Maria Tsoumani, Constantinos H. Davos, Ioanna Andreadou, Panagiota Nikolaou, Aimilia Varela and Panagiotis Efentakis and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zoi Kanaki

19 papers receiving 508 citations

Peers

Zoi Kanaki

SURGE

ONCOL

Rong Yan China

Chiara Barozzi Italy

Paz de la Torre Spain

Hikaru Matsuda Japan

Konstantina Kyriakopoulou Greece

Brittany N. Allen United States

Ihab Abd‐Elrahman Israel

Lingxiao Zhang China

Tania Fontanil Spain

Rong Yan China

Zoi Kanaki

375 ×1.5

99 ×0.8

SURGE

102 ×0.9

ONCOL

138 ×2.1

61 ×1.0

Citations per year, relative to Zoi Kanaki Zoi Kanaki (= 1×) peers Rong Yan

Countries citing papers authored by Zoi Kanaki

Since Specialization

Citations

This map shows the geographic impact of Zoi Kanaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoi Kanaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoi Kanaki more than expected).

Fields of papers citing papers by Zoi Kanaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoi Kanaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoi Kanaki. The network helps show where Zoi Kanaki may publish in the future.

Co-authorship network of co-authors of Zoi Kanaki

This figure shows the co-authorship network connecting the top 25 collaborators of Zoi Kanaki. A scholar is included among the top collaborators of Zoi Kanaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoi Kanaki. Zoi Kanaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Kanaki, Zoi, Giannis Vatsellas, Evangelos Giotakis, et al.. (2025). Regulation of nucleotide excision repair by wild-type HRAS signaling in head and neck cancer. Cancer Gene Therapy. 32(6). 662–677. 1 indexed citations

Papadimitriou, M., Konstantina Panoutsopoulou, Zoi Kanaki, et al.. (2024). CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients. SHILAP Revista de lepidopterología. 32(2). 200818–200818. 2 indexed citations

Vrettos, Eirinaios I., Vasiliki Zoi, Μaria V. Chatziathanasiadou, et al.. (2024). A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter‐Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine. Chemistry - A European Journal. 30(50). e202401327–e202401327. 2 indexed citations

Nika, Maria‐Christina, Zoi Kanaki, Simona Golič Grdadolnik, et al.. (2023). Development of a novel apigenin prodrug programmed for alkaline-phosphatase instructed self-inhibition to combat cancer. Journal of Biomolecular Structure and Dynamics. 42(16). 8638–8659. 3 indexed citations

Kanaki, Zoi, et al.. (2023). Development of a Method for the In Vivo Generation of Allogeneic Hearts in Chimeric Mouse Embryos. International Journal of Molecular Sciences. 24(2). 1163–1163. 2 indexed citations

Kanaki, Zoi, Nikolaos Paschalidis, Marina Makrygianni, et al.. (2023). Printed cisplatin on microneedle arrays for transdermal delivery enhances olaparib-induced synthetic lethality in a mouse model of homologous recombination deficiency. International Journal of Bioprinting. 9(6). 48–48. 4 indexed citations

Kanaki, Zoi, et al.. (2022). Laser-Induced Forward Transfer Printing on Microneedles for Transdermal Delivery of Gemcitabine. International Journal of Bioprinting. 8(2). 554–554. 17 indexed citations

Topalis, Pantelis, Anna Batistatou, Zoi Kanaki, et al.. (2021). Distinct roles of haspin in stem cell division and male gametogenesis. Scientific Reports. 11(1). 19901–19901. 12 indexed citations

Agalou, Adamantia, Μaria V. Chatziathanasiadou, Γεώργιος Μαρκόπουλος, et al.. (2021). Biotin-Yellow a biotin guided NIR turn-on fluorescent probe for cancer targeted diagnosis. Sensors and Actuators B Chemical. 337. 129807–129807. 12 indexed citations

10.

Kanaki, Zoi, Alexandra Voutsina, Athina Markou, et al.. (2021). Generation of Non-Small Cell Lung Cancer Patient-Derived Xenografts to Study Intratumor Heterogeneity. Cancers. 13(10). 2446–2446. 4 indexed citations

11.

Nikolaou, Panagiota, Panagiotis Efentakis, Saveria Femminò, et al.. (2020). Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress. Antioxidants and Redox Signaling. 34(7). 551–571. 65 indexed citations

12.

Ράμπιας, Θεόδωρος, Dimitris Karagiannis, Margaritis Avgeris, et al.. (2019). The lysine‐specific methyltransferase KMT 2C/ MLL 3 regulates DNA repair components in cancer. EMBO Reports. 20(3). 96 indexed citations

13.

Ράμπιας, Θεόδωρος, Margaritis Avgeris, Zoi Kanaki, et al.. (2019). Sensitizing HRAS overexpressing head and neck squamous cell carcinoma (HNSCC) to chemotherapy. Annals of Oncology. 30. v462–v463. 2 indexed citations

14.

Vasilaki, Eleni, Zoi Kanaki, Dimitrios J. Stravopodis, & Apostolos Klinakis. (2018). Dll1 Marks Cells of Origin of Ras-Induced Cancer in Mouse Squamous Epithelia. Translational Oncology. 11(5). 1213–1219. 4 indexed citations

15.

Efentakis, Panagiotis, Aimilia Varela, Panagiota Nikolaou, et al.. (2018). Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin. Blood. 133(7). 710–723. 94 indexed citations

16.

Efentakis, Panagiotis, Aimilia Varela, Constantinos H. Davos, et al.. (2018). Metformin Restores AMPK Alpha-Mediated Autophagy and Prevents Carfilzomib-Induced Cardiotoxicity In Vivo. Blood. 132(Supplement 1). 3214–3214. 1 indexed citations

17.

Karathanou, Konstantina, Zoi Kanaki, Νatassa Pippa, et al.. (2017). Magnetic nanoparticles coated with polyarabic acid demonstrate enhanced drug delivery and imaging properties for cancer theranostic applications. Scientific Reports. 7(1). 775–775. 57 indexed citations

18.

Papafotiou, George, et al.. (2016). KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nature Communications. 7(1). 11914–11914. 118 indexed citations

19.

Tiniakou, Ioanna, Zoi Kanaki, Spiros Georgopoulos, et al.. (2015). Natural human apoA-I mutations L141R Pisa and L159R FIN alter HDL structure and functionality and promote atherosclerosis development in mice. Atherosclerosis. 243(1). 77–85. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact